Stock 7AC ACARIX AB
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Acarix AB Deutsche Boerse AG

Equities

7AC

SE0009268717

Market Closed - Deutsche Boerse AG
Other stock markets
 03:11:14 2024-05-31 EDT 		5-day change 1st Jan Change
0.029 EUR +9.02% Intraday chart for Acarix AB +14.17% +90.79%
05-27 Acarix AB Appoints Jeff Thomas as the New Head of US Sales, Effective June 1, 2024 CI
05-14 Transcript : Acarix AB, Q1 2024 Earnings Call, May 14, 2024

Summary

  • On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.

Strengths

  • The prospective high growth for the next fiscal years is among the main assets of the company
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.

Weaknesses

  • As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
  • Low profitability weakens the company.
  • For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
  • The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
  • The group usually releases earnings worse than estimated.

Ratings chart - Surperformance

Sector: Advanced Medical Equipment & Technology

1st Jan change Capi. Investor Rating ESG Refinitiv
ACARIX AB Stock Acarix AB
+90.79% 28.59M -
SARTORIUS AG Stock Sartorius AG
-27.52% 16.33B
A
QUIDELORTHO CORPORATION Stock QuidelOrtho Corporation
-40.04% 2.96B
C+
INNER MONGOLIA FURUI MEDICAL SCIENCE CO., LTD. Stock Inner Mongolia Furui Medical Science Co., Ltd.
+15.16% 1.82B -
SHANGHAI MICROPORT EP MEDTECH CO., LTD. Stock Shanghai MicroPort EP MedTech Co., Ltd.
-6.86% 1.55B -
BIOTAGE AB Stock Biotage AB
+38.67% 1.41B
B+
SHANGHAI AOHUA PHOTOELECTRICITY ENDOSCOPE CO., LTD. Stock Shanghai AoHua Photoelectricity Endoscope Co., Ltd.
-15.36% 976M -
CONTEC MEDICAL SYSTEMS CO.,LTD Stock Contec Medical Systems Co.,Ltd
-26.08% 846M -
C-
REVENIO GROUP OYJ Stock Revenio Group Oyj
+3.53% 811M -
VAREX IMAGING CORPORATION Stock Varex Imaging Corporation
-24.63% 631M
B+
Investor Rating
Trading Rating
-
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances
-

Valuation

P/E ratio
-
EV / Sales
-
Price to Book
-
Price to Free Cash Flow
-
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality
  1. Stock Market
  2. Equities
  3. ACARIX Stock
  4. 7AC Stock
  5. Ratings Acarix AB